Acceptability and Feasibility of Micronutrient Powders Versus Iron Syrup for Anemia Prevention in Young Children

Overview

This study seeks to assess the acceptability, compliance, and preference for iron supplementation; micronutrient powders (MNP) versus iron syrup. Additionally, this study seeks to assess front line health worker perceptions and experiences regarding ease of implementation of each strategy and delivery strategy preference.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Crossover Assignment
    • Masking: None (Open Label)
  • Study Primary Completion Date: April 2016

Detailed Description

The specific aims of this study are to assess the acceptability of, compliance, and preference for two delivery vehicles for pediatric prophylaxis iron supplementation (micronutrient powders (MNP) that contain iron versus iron syrup) among rural households in Bihar India delivered through home visits by front line health workers. Additionally, this study seeks to assess front line health worker perceptions and experiences regarding ease of implementation of each strategy and delivery strategy preference.

Interventions

  • Dietary Supplement: Iron and Folic Acid (IFA)
    • 1 mg of IFA syrup (containing 20 mg of elemental iron and 100 mcg of folic acid) will be taken twice per week for one month.
  • Dietary Supplement: Micronutrient Powders (MNP)
    • One sachet of micronutrient powder will be mixed into food to be taken once daily for a total of one month. One sachet of micronutrient powders includes the following: Iron (Ferrous Fumarate) 12.5 mg Zinc (Zinc Gluconate) 5 mg Folic Acid 0.160 mg Vitamin-A (Vit-A Acetate) 0.30mg Vitamin-C (Ascorbic Acid) 30 mg Vitamin-B12 0.9 mcg Iodine 90 mcg Maltodextrin Base
  • Behavioral: Iron Plus Strategy Counseling
    • Mothers of participants will receive counseling on the benefits of regular iron intake, side effects associated with IFA administration, and the preservation of the IFA bottle and MNP sachets.

Arms, Groups and Cohorts

  • Experimental: Iron and Folic Acid (IFA)/Micronutrient Powders (MNP)
    • Participants will receive iron and folic acid (IFA) drops for one month followed by a two week washout period. Participants will then receive micronutrient powders (MNP) for one month. Mothers of participants will receive counseling on the benefits of iron intake, side effects of IFA, and preservation of IFA bottles and MNP sachets.
  • Experimental: Micronutrient Powders (MNP)/Iron and Folic Acid (IFA)
    • Participants will receive micronutrient powders (MNP) for one month followed by a two week washout period. Participants will then receive iron and folic acid (IFA) drops for one month. Mothers of participants will receive counseling on the benefits of iron intake, side effects of IFA, and preservation of IFA bottles and MNP sachets.

Clinical Trial Outcome Measures

Primary Measures

  • Acceptability of iron and folic acid (IFA) syrup
    • Time Frame: Endline (Up to 5 months)
    • Caregiver change in acceptability of iron and folic acid (IFA) syrup will be assessed using the Relative Preference, Acceptability, and Compliance of Iron Syrup versus Multiple Micronutrient Powders (MMP) Among Infants 6-23 Months in Bihar, India survey. This survey collects information regarding the use of iron and nutrient supplementation, barriers to usage, and attitudes towards usage.
  • Acceptability of micronutrient powders (MNP)
    • Time Frame: Endline (Up to 5 months)
    • Caregiver change in acceptability of micronutrient powders (MNP) will be assessed using the Relative Preference, Acceptability, and Compliance of Iron Syrup versus Multiple Micronutrient Powders (MMP) Among Infants 6-23 Months in Bihar, India survey. This survey collects information regarding the use of iron and nutrient supplementation, barriers to usage, and attitudes towards usage.
  • Preference for vitamin supplementation
    • Time Frame: Endline (Up to 5 months)
    • Caregiver change in preference for vitamin supplementation (IFA versus MNP) will be assessed using the Relative Preference, Acceptability, and Compliance of Iron Syrup versus Multiple Micronutrient Powders (MMP) Among Infants 6-23 Months in Bihar, India survey. This survey collects information regarding the use of iron and nutrient supplementation, barriers to usage, and attitu
  • Vitamin supplementation compliance
    • Time Frame: Baseline, Endline (Up to 5 months)
    • Caregiver change in vitamin supplementation compliance will be assessed using the Relative Preference, Acceptability, and Compliance of Iron Syrup versus Multiple Micronutrient Powders (MMP) Among Infants 6-23 Months in Bihar, India survey. This survey collects information regarding the use of iron and nutrient supplementation, barriers to usage, and attitudes towards usage.

Secondary Measures

  • Change in perceived barriers to vitamin supplementation
    • Time Frame: Baseline, Endline (Up to 5 months)
    • Caregiver change in perceived barriers to vitamin supplementation will be assessed using the Relative Preference, Acceptability, and Compliance of Iron Syrup versus Multiple Micronutrient Powders (MMP) Among Infants 6-23 Months in Bihar, India survey. This survey collects information regarding the use of iron and nutrient supplementation, barriers to usage, and attitudes towards usage.
  • Preferred method of distribution
    • Time Frame: Endline (Up to 5 months)
    • The preferred method of distribution will be discussed with front line workers in focus group discussions.

Participating in This Clinical Trial

Inclusion Criteria

  • Singleton Children or one child per home Exclusion Criteria:

  • Currently taking iron supplements – Mid upper arm circumference (MUAC) or less than 11.5 cm – Suspected severe anemia – Known case of haemoglobinopathy – History of repeated blood transfusion – Current pneumonia – Current fever – Acute diarrhea

Gender Eligibility: All

Minimum Age: 6 Months

Maximum Age: 23 Months

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Emory University
  • Collaborator
    • International Food Policy Research Institute
  • Provider of Information About this Clinical Study
    • Principal Investigator: Melissa Fox Young, Research Assistant Professor – Emory University
  • Overall Official(s)
    • Melissa Young, PhD, Principal Investigator, Emory University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.